Chai Discovery’s Chai-2: AI Redefines Antibody Design with a 20% Success Rate

Discover how Chai-2’s AI model achieves a groundbreaking 20% success rate in de novo antibody design, revolutionizing biotech and drug discovery.

Chai-2 by Chai Discovery sets a new standard in biotech, using AI to achieve a 20% hit rate in antibody design. Learn how this breakthrough is changing drug discovery.